No Data
No Data
Mineralys Therapeutics to Announce Second Quarter 2024 Financial Results and Host Conference Call on Tuesday, August 13, 2024
Form 144 | Mineralys Therapeutics(MLYS.US) Officer Proposes to Sell 7.18 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 24, $Mineralys Therapeutics(MLYS.US)$ Officer CATALYS PACIFIC FUND,LP intends to sell 550K shares of its common stock on Jul 24, with a total market value of
Mineralys Therapeutics Inc (MLYS) CEO Jon Congleton Sells 15,746 Shares
Insider Sale at Mineralys Therapeutics Inc (MLYS): CFO and Secretary Adam Levy Sells Shares
Mineralys Therapeutics Price Target Announced at $30.00/Share by HC Wainwright & Co.
Mineralys Therapeutics Analyst Ratings
No Data